|
No.a
|
Gender
|
Current age (years)
|
Newborn screening
|
Recall
|
Urine organic acids
|
Affected gene
|
Genotype
|
|---|
|
C5DC (µmol/L)
|
C0 (µmol/L)
|
C5DC (µmol/L)
|
C0 (µmol/L)
|
GA (mmol/mol creatinine)
|
3HGA (mmol/mol creatinine)
|
Allele 1
|
Allele 2
|
|---|
|
1
|
Female
|
37
|
1.07
|
4.00
|
1.15
|
5.92
|
579.6
|
29.11
|
GCDH
|
c.1244-2 A>C
|
c.1244-2 A>C
|
|
2
|
Male
|
5
|
0.07
|
4.12
|
0.04
|
5.84
|
N/A
|
N/A
|
GCDH
|
c.1244-2 A>C
| |
|
3
|
Female
|
34
|
0.76
|
2.46
|
N/A
|
N/A
|
N/A
|
N/A
|
GCDH
|
c.1063 C>T (p.Arg355Cys)
|
c.769 C>T (p.Arg257Trp)
|
|
4
|
Male
|
3
|
0.06
|
3.68
|
0.03
|
7.16
|
N/A
|
N/A
|
GCDH
|
c.769 C>T (p.Arg257Trp)
| |
- C5DC: glutarylcarnitine; C0: free carnitine, GA: glutaric acid, 3HGA: 3-hydroxyglutaric acid, N/A: not available
- Reference range, C5DC: 0.03–0.3 µmol/L, C0: 8.5–50 µmol/L, GA: < 2.5 mmol/mol creatinine, 3HGA: < 4.6 mmol/mol creatinine
- aNo. 1 and 3 are maternal GA1 patients, No. 2 and 4 are their infants, respectively